Jeffrey G. Spragens's Insider Trades & SAST Disclosures

Jeffrey G. Spragens's most recent trade in SAB Biotherapeutics Inc was a trade of 20,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on July 15, 2024.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
SAB Biotherapeutics Inc
Jeffrey G. Spragens Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jul 2024 20,000 20,000 - - Stock Option (right to buy)
SAB Biotherapeutics Inc
Jeffrey G. Spragens Director Other type of transaction at price $ 0.00 per share. 28 Feb 2023 19,936 19,936 - - Warrants
SAB Biotherapeutics Inc
Jeffrey G. Spragens Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Dec 2022 82,987 82,987 - - Warrant (Common Stock)
SAB Biotherapeutics Inc
Jeffrey G. Spragens Director Grant, award, or other acquisition of securities at price $ 1.20 per share. 07 Dec 2022 82,987 394,989 - 1.2 99,999 Common Stock
SAB Biotherapeutics Inc
Jeffrey G. Spragens Director Other type of transaction at price $ 0.00 per share. 20 May 2022 299,002 312,002 - 0 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades